Topp L - Search Results

1

The epidemiology of ecstasy use and harms in Australia.

Degenhardt L, Roxburgh A, Dunn M, Campbell G, Bruno R, Kinner SA, George J, Quinn B, White N, Topp L. Degenhardt L, et al. Among authors: topp l. Neuropsychobiology. 2009;60(3-4):176-87. doi: 10.1159/000253553. Epub 2009 Nov 5. Neuropsychobiology. 2009. PMID: 19893334

2

Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia.

Hando J, Topp L, Hall W. Hando J, et al. Among authors: topp l. Drug Alcohol Depend. 1997 Jun 6;46(1-2):105-13. doi: 10.1016/s0376-8716(97)00051-3. Drug Alcohol Depend. 1997. PMID: 9246558

3

Ecstasy use in Australia: patterns of use and associated harm.

Topp L, Hando J, Dillon P, Roche A, Solowij N. Topp L, et al. Drug Alcohol Depend. 1999 Jun 1;55(1-2):105-15. doi: 10.1016/s0376-8716(99)00002-2. Drug Alcohol Depend. 1999. PMID: 10402155

4

The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system.

Topp L, Degenhardt L, Kaye S, Darke S. Topp L, et al. Drug Alcohol Rev. 2002 Dec;21(4):341-8. doi: 10.1080/0959523021000023199. Drug Alcohol Rev. 2002. PMID: 12537703

5

Contemplating drug monitoring systems in the light of Australia's "heroin shortage".

Topp L, Degenhardt L, Day C, Collins L. Topp L, et al. Drug Alcohol Rev. 2003 Mar;22(1):3-6. doi: 10.1080/0959523021000059767. Drug Alcohol Rev. 2003. PMID: 12745352 No abstract available.

6

The monitoring of drug trends in Australia.

Shand F, Topp L, Darke S, Makkai T, Griffiths P. Shand F, et al. Among authors: topp l. Drug Alcohol Rev. 2003 Mar;22(1):61-72. doi: 10.1080/0959523021000059848. Drug Alcohol Rev. 2003. PMID: 12745360 Review.

7

Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia.

Topp L, Day C, Degenhardt L. Topp L, et al. Drug Alcohol Depend. 2003 Jun 5;70(3):275-86. doi: 10.1016/s0376-8716(03)00013-9. Drug Alcohol Depend. 2003. PMID: 12757965

8

The external validity of results derived from ecstasy users recruited using purposive sampling strategies.

Topp L, Barker B, Degenhardt L. Topp L, et al. Drug Alcohol Depend. 2004 Jan 7;73(1):33-40. doi: 10.1016/j.drugalcdep.2003.09.001. Drug Alcohol Depend. 2004. PMID: 14687957

9

Patterns of ecstasy use in Australia: findings from a national household survey.

Degenhardt L, Barker B, Topp L. Degenhardt L, et al. Among authors: topp l. Addiction. 2004 Feb;99(2):187-95. doi: 10.1111/j.1360-0443.2003.00622.x. Addiction. 2004. PMID: 14756711

10

Prevalence and predictors of injecting-related injury and disease among clients of Australia's needle and syringe programs.

Topp L, Iversen J, Conroy A, Salmon AM, Maher L; Collaboration of Australian NSPs. Topp L, et al. Aust N Z J Public Health. 2008 Feb;32(1):34-7. doi: 10.1111/j.1753-6405.2008.00163.x. Aust N Z J Public Health. 2008. PMID: 18290911 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters